Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Arcus Biosciences Inc (RCUS)  
$14.73 0.70 (4.54%) as of 4:30 Thu 4/25


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 64,920,000
Market Cap: 956.27(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $13.43 - $23.54
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    : 31.4
Insider 6 Months    : 31.4
Insider 3/6 Months : 63.1
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Arcus Biosciences is a clinical-stage biopharmaceutical company focused on creating cancer therapies. Co.'s products include: Domvanalimab, which is an anti-TIGIT monoclonal antibody designed to promote sustained immune activation and tumor clearance; Etrumadenant, which is a dual A2a/A2b adenosine receptor antagonist, designed to inhibit the adenosine-driven impairment of tumor-infiltrating lymphocytes and myeloid cells; AB680, which is a potent and selective small-molecule CD73 inhibitor designed to provide differential benefits relative to monoclonal antibodies; and Zimberelimab, which is Co.'s anti-PD-1 antibody that Co. in-licensed to enable the development of its combination regimens.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 15,238,095 15,238,095 16,248,095 16,248,095
Total Buy Value $319,999,995 $319,999,995 $339,452,595 $339,452,595
Total People Bought 1 1 1 1
Total Buy Transactions 1 1 2 2
Total Shares Sold 110,657 141,439 237,875 329,459
Total Sell Value $2,164,815 $2,731,452 $4,652,676 $7,003,905
Total People Sold 2 4 4 6
Total Sell Transactions 6 10 16 33
End Date 2024-01-25 2023-10-24 2023-04-25 2022-04-25

   
Records found: 56
  Page 1 of 3  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Rosen Terry J Chief Executive Officer   •       •      –    2021-06-17 4 S $23.68 $115,156 D/D (4,863) 205,562 -45%     
   Jaen Juan C. President   •       •      –    2021-06-17 4 S $23.68 $63,344 D/D (2,675) 198,286 -45%     
   Tang Carolyn C. General Counsel   •       –      –    2021-06-17 4 S $23.68 $38,030 D/D (1,606) 15,362 -45%     
   Jarrett Jennifer Chief Operating Officer   •       •      –    2021-06-17 4 S $23.68 $115,156 D/D (4,863) 135,343 -45%     
   Grossman William Chief Medical Officer   •       –      –    2021-06-17 4 S $23.68 $92,139 D/D (3,891) 20,723 -45%     
   Rosen Terry J Chief Executive Officer   •       •      –    2021-06-16 4 S $24.13 $95,850 D/D (3,968) 210,425 -47%     
   Jaen Juan C. President   •       •      –    2021-06-16 4 S $24.13 $52,707 D/D (2,182) 200,961 -47%     
   Tang Carolyn C. General Counsel   •       –      –    2021-06-16 4 S $24.13 $31,619 D/D (1,309) 16,968 -47%     
   Jarrett Jennifer Chief Operating Officer   •       •      –    2021-06-16 4 S $24.13 $95,850 D/D (3,968) 140,206 -47%     
   Grossman William Chief Medical Officer   •       –      –    2021-06-16 4 S $24.13 $76,670 D/D (3,174) 24,614 -47%     
   Jarrett Jennifer Chief Operating Officer   •       •      –    2021-06-04 4 S $24.91 $26,006 D/D (1,044) 119,174 -26%     
   Falberg Kathryn E Director   –       •      –    2021-06-03 4 A $0.00 $0 D/D 3,000 86,504     -
   Kaneko Yasunori Director   –       •      –    2021-06-03 4 A $0.00 $0 D/D 3,000 6,000     -
   Lacey David L. Director   –       •      –    2021-06-03 4 A $0.00 $0 D/D 3,000 38,352     -
   Perlman Andrew J Director   –       •      –    2021-06-03 4 A $0.00 $0 D/D 3,000 5,525     -
   Ribas Antoni Director   –       •      –    2021-06-03 4 A $0.00 $0 D/D 3,000 11,050     -
   Machado Clarence Patrick Director   –       •      –    2021-06-03 4 A $0.00 $0 D/D 3,000 6,000     -
   Kaneko Yasunori Director   –       •      –    2021-04-23 4 B $31.37 $129,652 D/D 4,133 7,133 2.39 -12%     
   Grossman William Chief Medical Officer   •       –      –    2021-04-23 4 S $31.37 $129,652 D/D (4,133) 6,717 12%     
   Falberg Kathryn E Director   –       •      –    2021-03-31 4 B $28.35 $566,996 I/I 20,000 102,106 2.1 2%     
   Jarrett Jennifer Chief Operating Officer   •       •      –    2021-03-16 4 S $35.03 $303,394 D/D (8,661) 116,973 7%     
   Grossman William Chief Medical Officer   •       –      –    2021-03-16 4 S $35.03 $74,509 D/D (2,127) 10,850 7%     
   Rosen Terry J Chief Executive Officer   •       •      –    2021-02-01 4 GD $0.00 $0 I/I 311,900 0     -
   Gilead Sciences Inc 10% Owner   –       –       •   2021-01-31 4 B $39.00 $220,350,000 D/D 5,650,000 13,913,029 2.45 -35%     
   Rosen Terry J Chief Executive Officer   •       •      –    2021-01-19 4 A $0.00 $0 D/D 45,000 234,393     -
  56 Records found
  1  2  3   
  Page 1 of 3
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us